BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chan W, Chen A, Tiao D, Selinger C, Leong R. Medication adherence in inflammatory bowel disease. Intest Res 2017;15:434-45. [PMID: 29142511 DOI: 10.5217/ir.2017.15.4.434] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 9.4] [Reference Citation Analysis]
Number Citing Articles
1 Parfenov AI, Kagramanova AV, Babayan AF, Knyazev OV. Adherence to therapy of patients with inflammatory bowel diseases. Ter Arkh 2018;90:4-11. [PMID: 30701826 DOI: 10.26442/00403660.2018.12.000001] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Alonso-Abreu I, Alarcón-Fernández O, Carrillo-Palau M, Ramos-López L, Gisbert JP, Chaparro M, Nos P, Jiménez A, Quintero-Carrión E; en representación de GETECCU. Survey of adherence to treatment in inflammatory bowel disease. ENADEII study. Gastroenterol Hepatol 2020;43:285-92. [PMID: 31948830 DOI: 10.1016/j.gastrohep.2019.10.007] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H;  IBD guidelines eDelphi consensus group; Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68:s1-s106. [PMID: 31562236 DOI: 10.1136/gutjnl-2019-318484] [Cited by in Crossref: 361] [Cited by in F6Publishing: 297] [Article Influence: 120.3] [Reference Citation Analysis]
4 Kamp KJ, Luo Z, Holmstrom A, Given B, Wyatt G. Self-Management Through Social Support Among Emerging Adults With Inflammatory Bowel Disease. Nurs Res 2019;68:285-95. [PMID: 31265438 DOI: 10.1097/NNR.0000000000000354] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Carmody JK, Plevinsky J, Peugh JL, Denson LA, Hyams JS, Lobato D, LeLeiko NS, Hommel KA. Longitudinal non-adherence predicts treatment escalation in paediatric ulcerative colitis. Aliment Pharmacol Ther 2019;50:911-8. [PMID: 31373712 DOI: 10.1111/apt.15445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mazieiro R, Frizon RR, Barbalho SM, Goulart RA. Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases? J Med Food 2018;21:1077-85. [PMID: 29957091 DOI: 10.1089/jmf.2017.0146] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
7 Rossides M, Kullberg S, Di Giuseppe D, Eklund A, Grunewald J, Askling J, Arkema EV. Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective 'target trial' emulated with Swedish real-world data. Respirology 2021;26:452-60. [PMID: 33398914 DOI: 10.1111/resp.14001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fallahi F, Borran S, Ashrafizadeh M, Zarrabi A, Pourhanifeh MH, Khaksary Mahabady M, Sahebkar A, Mirzaei H. Curcumin and inflammatory bowel diseases: From in vitro studies to clinical trials. Mol Immunol 2021;130:20-30. [PMID: 33348246 DOI: 10.1016/j.molimm.2020.11.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Hong SN. Clinical usefulness of remote patient monitoring using e-Health technologies in patients with inflammatory bowel diseases. Korean J Intern Med. 2018;33:876-878. [PMID: 30180515 DOI: 10.3904/kjim.2018.298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Harris C, Cummings JRF. JAK1 inhibition and inflammatory bowel disease. Rheumatology (Oxford) 2021;60:ii45-51. [PMID: 33950226 DOI: 10.1093/rheumatology/keaa896] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Santos JDM, Peña-Sánchez JN, Fowler SA. Patients' perspectives on medication for inflammatory bowel disease: a mixed-method systematic review. Eur J Gastroenterol Hepatol 2021;33:1139-47. [PMID: 32773507 DOI: 10.1097/MEG.0000000000001861] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Plevinsky JM, Denson LA, Hellmann J, Minar P, Rosen MJ, Hommel KA. A Micro-longitudinal Approach to Measuring Medication Adherence in Pediatric Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr 2020;71:366-70. [PMID: 32404759 DOI: 10.1097/MPG.0000000000002778] [Reference Citation Analysis]
13 Bonaz B, Sinniger V, Pellissier S. Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases. Front Neurosci 2021;15:650971. [PMID: 33828455 DOI: 10.3389/fnins.2021.650971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lee JH, Lee SH, Ban GY, Ye YM, Nahm DH, Park HS, Shin YS. Factors Associated with Adherence to Allergen Specific Subcutaneous Immunotherapy. Yonsei Med J 2019;60:570-7. [PMID: 31124341 DOI: 10.3349/ymj.2019.60.6.570] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
15 Stone JK, Shafer LA, Graff LA, Lix L, Witges K, Targownik LE, Haviva C, Sexton K, Bernstein CN. Utility of the MARS-5 in Assessing Medication Adherence in IBD. Inflamm Bowel Dis 2021;27:317-24. [PMID: 32195533 DOI: 10.1093/ibd/izaa056] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Wall CL, McCombie A, Mulder R, Day AS, Gearry RB. Adherence to exclusive enteral nutrition by adults with active Crohn's disease is associated with conscientiousness personality trait: a sub-study. J Hum Nutr Diet 2020;33:752-7. [PMID: 32627898 DOI: 10.1111/jhn.12787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 El-Dallal M, Saroufim A, Systrom H, Ballou S, Farhoud A, Pasam RT, Gadupudi SS, Osman K, Chaudrey K, Cheifetz A, Feuerstein JD. Assessing the repercussions of COVID-19 pandemic on symptoms, disease management, and emotional well-being in patients with inflammatory bowel disease: a multi-site survey study. Scand J Gastroenterol 2021;:1-9. [PMID: 34894999 DOI: 10.1080/00365521.2021.2013527] [Reference Citation Analysis]
18 Sinniger V, Pellissier S, Fauvelle F, Trocmé C, Hoffmann D, Vercueil L, Cracowski J, David O, Bonaz B. A 12‐month pilot study outcomes of vagus nerve stimulation in Crohn's disease. Neurogastroenterology & Motility 2020;32. [DOI: 10.1111/nmo.13911] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
19 Prasad SS, Duncanson K, Keely S, Talley NJ, Kairuz T, Holtmann GJ, Shah A, Walker MM. A Role for Primary Care Pharmacists in the Management of Inflammatory Bowel Disease? Lessons from Chronic Disease: A Systematic Review. Pharmacy (Basel) 2020;8:E204. [PMID: 33147771 DOI: 10.3390/pharmacy8040204] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Plevinsky JM, Wojtowicz AA, Miller SA, Greenley RN. Longitudinal Barriers to Thiopurine Adherence in Adolescents With Inflammatory Bowel Diseases. J Pediatr Psychol 2019;44:52-60. [PMID: 30137372 DOI: 10.1093/jpepsy/jsy062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Alefishat E, Jarab AS, Al-Qerem W, Abu-Zaytoun L. Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia. Healthcare (Basel) 2021;9:813. [PMID: 34203226 DOI: 10.3390/healthcare9070813] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Sandall AM, Cox SR, Lindsay JO, Gewirtz AT, Chassaing B, Rossi M, Whelan K. Emulsifiers Impact Colonic Length in Mice and Emulsifier Restriction is Feasible in People with Crohn's Disease. Nutrients 2020;12:E2827. [PMID: 32942699 DOI: 10.3390/nu12092827] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
23 Lambert K, Pappas D, Miglioretto C, Javadpour A, Reveley H, Frank L, Grimm MC, Samocha-Bonet D, Hold GL. Systematic review with meta-analysis: dietary intake in adults with inflammatory bowel disease. Aliment Pharmacol Ther 2021;54:742-54. [PMID: 34323292 DOI: 10.1111/apt.16549] [Reference Citation Analysis]
24 Ma C, Battat R, Dulai PS, Parker CE, Sandborn WJ, Feagan BG, Jairath V. Innovations in Oral Therapies for Inflammatory Bowel Disease. Drugs 2019;79:1321-35. [PMID: 31317509 DOI: 10.1007/s40265-019-01169-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
25 Tse CS, Siegel CA, Weaver SA, Oliver BJ, Bresee C, van Deen WK, Melmed GY. Health Confidence Is Associated With Disease Outcomes and Health Care Utilization in Inflammatory Bowel Disease: A Nationwide Cross-sectional Study. Inflamm Bowel Dis 2021:izab313. [PMID: 34893849 DOI: 10.1093/ibd/izab313] [Reference Citation Analysis]
26 Sherwin LB, Ross D, Matteson-Kome M, Bechtold M, Deroche C, Wakefield B. Patient Perspectives on Short-Course Pharmacotherapy: Barriers and Facilitators to Medication Adherence. J Patient Exp 2020;7:726-33. [PMID: 33294608 DOI: 10.1177/2374373519882230] [Reference Citation Analysis]
27 Rahman SU, Li Y, Huang Y, Zhu L, Feng S, Wu J, Wang X. Treatment of inflammatory bowel disease via green tea polyphenols: possible application and protective approaches. Inflammopharmacol 2018;26:319-30. [DOI: 10.1007/s10787-018-0462-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 7.8] [Reference Citation Analysis]
28 Reuken PA, Grunert PC, Lügering A, Teich N, Stallmach A. Self-assessment of treatment targets in patients with inflammatory bowel disease using a survey. Therap Adv Gastroenterol 2020;13:1756284820971213. [PMID: 33240395 DOI: 10.1177/1756284820971213] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Friedman AB, Asthana A, Knowles SR, Robbins A, Gibson PR. Effect of point-of-care gastrointestinal ultrasound on decision-making and management in inflammatory bowel disease. Aliment Pharmacol Ther 2021;54:652-66. [PMID: 34157157 DOI: 10.1111/apt.16452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Gohil S, Majd Z, Sheneman JC, Abughosh SM. Interventions to improve medication adherence in inflammatory bowel disease: A systematic review. Patient Educ Couns 2021:S0738-3991(21)00676-5. [PMID: 34736829 DOI: 10.1016/j.pec.2021.10.017] [Reference Citation Analysis]
31 Mariano LNB, Arruda C, Somensi LB, Costa APM, Perondi EG, Boeing T, Mariott M, da Silva RDCMVDA, de Souza P, Bastos JK, de Andrade SF, da Silva LM. Brazilian green propolis hydroalcoholic extract reduces colon damages caused by dextran sulfate sodium-induced colitis in mice. Inflammopharmacol 2018;26:1283-92. [DOI: 10.1007/s10787-018-0467-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
32 Barker DH, Shapiro JM, Lobato D, McQuaid EL, Leleiko NS. Challenges and Approaches to Assessing Medication Adherence in Pediatric Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr 2020;70:759-61. [PMID: 32443027 DOI: 10.1097/MPG.0000000000002727] [Reference Citation Analysis]
33 Lee S, Seow CH, Adhikari K, Metcalfe A. Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications. Aliment Pharmacol Ther 2020;51:544-52. [DOI: 10.1111/apt.15596] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
34 Shrestha N, Xu Y, Prévost JRC, McCartney F, Brayden D, Frédérick R, Beloqui A, Préat V. Impact of PEGylation on antibody-loaded nanoparticulate drug delivery system on treatment of inflammatory bowel disease. Acta Biomater 2021:S1742-7061(21)00822-9. [PMID: 34923097 DOI: 10.1016/j.actbio.2021.12.015] [Reference Citation Analysis]
35 Nieto JC, Arajol C, Carmona L, Marras C, Cea-Calvo L. Adherence to subcutaneous biological therapies in patients with inflammatory rheumatic diseases and inflammatory bowel disease: a systematic review. Immunotherapy 2021;13:433-58. [PMID: 33557600 DOI: 10.2217/imt-2021-0011] [Reference Citation Analysis]
36 Park SK, Park SH, Eun CS, Seo GS, Im JP, Kim TO, Park DI. Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study. Intest Res 2019;17:349-56. [PMID: 30727712 DOI: 10.5217/ir.2018.00064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
37 Guven S, Koylu MT, Mumcuoglu T. Adherence to glaucoma medication, illness perceptions, and beliefs about glaucoma: Attitudinal perspectives among Turkish population. Eur J Ophthalmol 2021;31:469-76. [PMID: 32019338 DOI: 10.1177/1120672120901687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Gely C, Marín L, Gordillo J, Mañosa M, Bertoletti F, Cañete F, González-Muñoza C, Calafat M, Domènech E, Garcia-Planella E. Impact of pain associated with the subcutaneous administration of adalimumab. Gastroenterol Hepatol 2020;43:9-13. [PMID: 31492425 DOI: 10.1016/j.gastrohep.2019.06.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
39 Perry J, Chen A, Kariyawasam V, Collins G, Choong C, Teh WL, Mitrev N, Kohler F, Leong RWL. Medication non-adherence in inflammatory bowel diseases is associated with disability. Intest Res 2018;16:571-8. [PMID: 30301333 DOI: 10.5217/ir.2018.00033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
40 Fenwick S, Thakur K, Munro D. Nurse and Patient Perceptions and Preferences for Subcutaneous Autoinjectors for Inflammatory Joint or Bowel Disease: Findings from a European Survey. Rheumatol Ther 2019;6:195-206. [PMID: 30790242 DOI: 10.1007/s40744-019-0144-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]